Therapeutic Potential of Targeting Plasminogen Activator Inhibitor-1 in COVID-19

Trends Pharmacol Sci. 2021 Jun;42(6):431-433. doi: 10.1016/j.tips.2021.03.006. Epub 2021 Mar 26.

Abstract

Latest research shows that SERPINE1 overexpression has an important role in Coronavirus 2019 (COVID-19)-associated coagulopathy leading to acute respiratory distress syndrome (ARDS). However, ways to target this protein remain elusive. In this forum, we discuss recent evidence linking SERPINE1 with COVID-19-related ARDS and summarize the available data on inhibitors of this target.

Publication types

  • Comment

MeSH terms

  • COVID-19*
  • Complement Activation
  • Humans
  • Respiratory Distress Syndrome*
  • SARS-CoV-2